Stock Analysis
Kaori Heat Treatment Third Quarter 2024 Earnings: EPS Beats Expectations
Kaori Heat Treatment (TWSE:8996) Third Quarter 2024 Results
Key Financial Results
- Revenue: NT$1.21b (up 5.4% from 3Q 2023).
- Net income: NT$207.0m (flat on 3Q 2023).
- Profit margin: 17% (in line with 3Q 2023).
- EPS: NT$2.27.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Kaori Heat Treatment EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 32%.
Looking ahead, revenue is forecast to grow 45% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Machinery industry in Taiwan.
Performance of the Taiwanese Machinery industry.
The company's shares are up 3.4% from a week ago.
Risk Analysis
You should learn about the 1 warning sign we've spotted with Kaori Heat Treatment.
Valuation is complex, but we're here to simplify it.
Discover if Kaori Heat Treatment might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TWSE:8996
Kaori Heat Treatment
Engages in the research, development, manufacture, and sale of heat exchanger solutions in Taiwan, rest of Asia, the United States, Europe, and internationally.